The Female Health Company Schedules Year End FY2008 Conference Call for Decemb...( CHICAGO Nov. 24 /- The Female Health ...),Health

CHICAGO, Nov. 24 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC) today announced that it will host an investor conference call to discuss its operating results for the fiscal year ended September 30, 2008 at 11:00 a.m. Eastern Time (EST) on Monday, December 1, 2008. The Company plans to report its FY2008 operating results earlier the same day.

Shareholders and other interested parties may participate in the conference call by dialing 800-860-2442 (international participants dial 412-858-4600) and asking to be connected to the 'Female Health Company Conference Call,' a few minutes before 11:00 a.m. EST on December 1, 2008. A replay of the call will be available one hour after the call through 5:00 pm on December 15, 2008 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 425576.

About The Female Health Company

The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. Patents are pending for FC2. FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world. The Female Health Company and its partners currently market the Female Condom under FC Female Condom(R), FC2 Female Condom(R), Reality(R), Femidom(R), Femy(R), and Care(R) in the rest of the world.'/>"/>